Zobrazeno 1 - 10
of 1 766
pro vyhledávání: '"Nylander, S."'
39. Bombus (Bombus) patagiatus Nylander s. l. (Fig. 42) Bombus patagiatus Nylander, 1848: 234, type not found (Tkalců, 1967). Russia: ���E Sibiria���. Bombus terrestris var. patagiatus Nylander; Morawitz, 1890: 349. China: ���
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473109231300ba22f2c210b3b6d89c31
Autor:
Pehrsson, S., Johansson, K. J, Janefeldt, A., Sandinge, A.‐S., Maqbool, S., Goodman, J., Sanchez, J., Almquist, J., Gennemark, P., Nylander, S. *
Publikováno v:
In Journal of Thrombosis and Haemostasis June 2017 15(6):1213-1222
Publikováno v:
In Journal of Thrombosis and Haemostasis December 2016 14(12):2342-2352
Autor:
Birnbaum Y; The Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Chen H; The Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, 301 University Blvd, BSB 648, Galveston, TX, 77555, USA.; Department of Acupuncture, First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Tran D; School of Medicine, University of Texas Medical Branch, Galveston, TX, USA., Nylander S; Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden., Ye Y; The Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, 301 University Blvd, BSB 648, Galveston, TX, 77555, USA. yumye@utmb.edu.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2022 Oct; Vol. 36 (5), pp. 829-840. Date of Electronic Publication: 2021 Jul 07.
Publikováno v:
In Journal of Thrombosis and Haemostasis August 2015 13(8):1494-1502
Autor:
Nylander, S. *, Femia, E.A., Scavone, M., Berntsson, P., Asztély, A.‐K., Nelander, K., Löfgren, L., Nilsson, R.G., Cattaneo, M.
Publikováno v:
In Journal of Thrombosis and Haemostasis October 2013 11(10):1867-1876
Autor:
NYLANDER, S. *, KULL, B., BJÖRKMAN, J.A., ULVINGE, J.C., OAKES, N., EMANUELSSON, B.M., ANDERSSON, M., SKÄRBY, T., INGHARDT, T., FJELLSTRÖM, O., GUSTAFSSON, D.
Publikováno v:
In Journal of Thrombosis and Haemostasis October 2012 10(10):2127-2136
Autor:
E. Strauss
Publikováno v:
The American Journal of the Medical Sciences. 144:598
Autor:
Cohen TS; Microbiome Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, 20878, USA. taylor.cohen@astrazeneca.com., Kelly EJ; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Nylander S; Clinical Development, Vaccines and Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bansal H; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Jepson BM; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Bhuyan P; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA., Falsey AR; University of Rochester Medical Center, Rochester, NY, USA.
Publikováno v:
Scientific reports [Sci Rep] 2022 May 13; Vol. 12 (1), pp. 7961. Date of Electronic Publication: 2022 May 13.
Autor:
Johnston SC; Dean's Office, Dell Medical School, University of Texas at Austin (S.C.J.)., Amarenco P; Department of Neurology and Stroke Center, Bichat Hospital, Paris University, France (P.A.)., Aunes M; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.)., Denison H; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.)., Evans SR; Biostatistics Center, George Washington University (S.R.E.)., Himmelmann A; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.)., Jahreskog M; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.)., James S; Department of Medical Sciences, Uppsala University, Sweden (S.J.)., Knutsson M; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.)., Ladenvall P; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.)., Molina CA; Stroke Unit, Hospital Vall d'Hebron, Barcelona, Spain (C.A.M.)., Nylander S; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.)., Röther J; Department of Neurology, Asklepios Klinik Altona, Hamburg, Germany (J.R.)., Wang Y; Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing, China (Y.W.).
Publikováno v:
Stroke [Stroke] 2021 Nov; Vol. 52 (11), pp. 3482-3489. Date of Electronic Publication: 2021 Sep 03.